All data is managed in accordance with Singapore PDPA.

China Market Entry

Current Challenges & Our Bridge

For global medical aesthetic manufacturers seeking successful entry in China, AlphaMed Solutions is the strategic advisory firm that eliminates market entry risks. Unlike general consulting firms, we leverage a top-tier network of local industry experts and Global & China KOLs to deliver precise regulatory guidance and commercialization strategies, ensuring your global innovation achieves commercial excellence in China.

Competitive Local Players

Class III Classification Burden

Evolving Regulatory Compliance

Increasing Local Trial Demands

Intensive New Product Launches

Asian Chinese Beauty Needs

Different Clinical Practice Realities

Complex Commercial Operation

What We Do

Integrated support from product development to commercial launch

Our workstreams can be delivered independently or combined into a coordinated China market-entry program.

Regulatory & Clinical Development

Define the China registration pathway and build a locally credible evidence package.

Scope of work
  • Product classification: Device Class II, Class III or Cosmetic
  • Gap analysis against Chinese regulatory requirements
  • Local clinical trial design and market reference
  • NMPA dossier preparation, translation and submission
  • PV, quality infrastructure and governance support
  • China artwork, labeling and product information review
  • Local sample testing and inspection readiness

Medical Affairs

Create a local clinical narrative and activate the right expert community.

Scope of work
  • China medical strategy and clinical narrative
  • Top-tier Chinese KOL identification and engagement
  • Advisory board design and facilitation
  • Medical blueprint and annual activity plan
  • Scientific training and medical education
  • Local medical story and initiative development

Commercial Strategy & GTM

Translate market insight into positioning, channel choices and launch readiness.

Scope of work
  • Competitor pricing, market sizing and consumer demographics
  • China pricing structure and product positioning
  • National distributor, clinic and hospital-chain mapping
  • Brand localization and high-level marketing plan
  • Market access and commercial launch preparation
  • Business development and partner evaluation

Staff Outsourcing & Operations

Provide experienced interim leadership and hands-on local execution capacity.

Scope of work
  • Interim Country Manager
  • Interim Sales Director
  • Interim Medical Director
  • Commercial operations support
  • Launch coordination and local execution
  • Capability building and governance

Business Development & Licensing

Business development and licensing outlook

Creating cross-border pathways for differentiated medical aesthetics assets, technologies and commercial partnerships.

In-Licensing

Global to China

  • Source novel, high-barrier global assets
  • Next-generation biostimulators
  • Novel energy-based devices
  • Match assets with Chinese pharmaceutical and aesthetics companies

Out-Licensing

China to Global

  • Identify high-quality domestic manufacturers
  • Support export of cost-competitive equipment
  • Develop routes to emerging global markets
  • Build international distribution and commercial partnerships

Deal Structuring

Transaction Support

  • Asset valuation
  • Commercial and strategic due diligence
  • Partner identification and negotiation support
  • Upfront, milestone and royalty term-sheet structures

Privacy Commitment

Confidentiality and security come first

AlphaMed Solutions manages personal information in accordance with Singapore’s Personal Data Protection Act (PDPA). We prioritize the confidentiality, responsible handling and security of information shared by clients, partners and website visitors.

Information shared with AlphaMed Solutions is handled for legitimate business and communication purposes with appropriate attention to confidentiality, privacy and responsible data practices.